Business of Supply  Mr. Speaker, the member is misleading Canadians. People die of overdoses because of the illegal toxic drug supply. Decriminalization is simply one tool of many in order to direct people to health services rather than putting them through the justice system. I would think that he would not want to stigmatize or criminalize those who need health care.

Business of Supply  Mr. Speaker, the government has dedicated over a billion dollars to this public health crisis, as opposed to the opposition. When it was in power, it cut two-thirds of the paltry $60 million that it put toward saving lives.

Business of Supply  Mr. Speaker, we are committed to saving lives with a comprehensive strategy that considers every tool and resource available, working with jurisdictions.

Business of Supply  Mr. Speaker, the member does not seem to be familiar with international jurisdictions that have also implemented decriminalization tools.

Business of Supply  Mr. Speaker, we are committed to working in partnership and collaboration with jurisdictions that wish to address this public health crisis with a robust set of tools, just as we have been committed to using evidence and expertise to save lives.

Business of Supply  Every death is a tragedy, Mr. Speaker, but the people are dying from an illegal toxic drug supply, not decriminalization, which is a tool that has been used in such countries as Germany, Portugal, Spain and Switzerland. If time allows, I will continue with the list.

Business of Supply  Mr. Speaker, I do not.

Business of Supply  Mr. Speaker, to my knowledge, no one from my office has met with Fair Price Pharma.

Business of Supply  Mr. Speaker, to my knowledge, no one on my team has met with Fair Price Pharma.

Business of Supply  Mr. Speaker, to my knowledge, my predecessor, then minister Bennett, met with Fair Price Pharma, but I am not sure what member of her team met with it.

Business of Supply  Mr. Speaker, I believe I answered the question previously. I will reiterate that I have not met with Fair Price Pharma. If a member of my team has met with Fair Price Pharma, the member already has the answer.

Business of Supply  Mr. Speaker, I have not met with Fair Price Pharma. Our prescribed alternative programs and the drugs distributed are paid for and prescribed by the provinces.

Business of Supply  Mr. Speaker, the member does not seem to appreciate the importance of collaborative work between the federal government and jurisdictions in addressing the overdose crisis. We will continue to work with all jurisdictions, as per their requests, on what we can do to save lives.

Business of Supply  Mr. Speaker, the federal government will always work with its provincial and municipal partners to ensure that we—

Business of Supply  Mr. Speaker, we do not work in hypotheticals; we work with facts.